Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Former longtime analyst Jami Rubin resigns from EQRx's CFO role
3 years ago
Updated: Carl Icahn proposes three new Illumina board members in proxy fight
3 years ago
Startups
Olema Oncology to cut 25% of staff, says it will focus on late-stage pipeline
3 years ago
R&D
UMass medical school’s manufacturing unit lays off 26 employees
3 years ago
Manufacturing
Coherus BioSciences lays off 20% of staff, while antimicrobial biotech makes deeper cuts
3 years ago
Neoleukin sends 70% of staff packing as IL-2 biotech searches for sale or other exit
3 years ago
Oncopeptides exec is arrested in Sweden for allegedly passing insider information
3 years ago
Law
Biotech pain continues as Versant, MPM gene therapy startup calls it quits
3 years ago
Cell/Gene Tx
Alex Denner's firm takes over Amarin, ousts non-Sarissa board members
3 years ago
Mental health-focused atai chops 30% of staff to 'further focus' on looming readouts
3 years ago
French CAR-T biotech Mnemo Therapeutics shutters US operations
3 years ago
Cell/Gene Tx
‘Harder to find homes’: Latest wave of biotech layoffs could test the industry
3 years ago
In Focus
Senate health committee chair demands Novo, Sanofi drop insulin costs after Lilly
3 years ago
Pharma
Akorn Pharmaceuticals files for bankruptcy, closes facilities and will liquidate
3 years ago
Pharma
Manufacturing
MorphoSys chops back again, this time cutting preclinical efforts in late-stage push
3 years ago
R&D
Ex-AveXis crew trims staff at Chicago-area Jaguar Gene Therapy
3 years ago
Cell/Gene Tx
Alex Denner secures victory in Amarin vote, ousting chair and adding supporters to board
3 years ago
G1 Therapeutics delays PhIII readout of lead drug — will cut 30% of staff, CFO to exit
3 years ago
R&D
Theravance cuts 17% of staff, JAK inhibitor program
3 years ago
R&D
Activist investor pushes for management overhaul, strategic review at Theravance
3 years ago
Tiny Apexigen to lay off majority of workers after SPAC deal
3 years ago
Who’s charting paths for LGBTQ+ leaders in biopharma? Nominate them for Endpoints’ annual report
3 years ago
Glenmark's biotech company Ichnos Sciences lays off 50
3 years ago
Ready for retirement, Juan Andres is waving goodbye to Moderna in May
3 years ago
Manufacturing
First page
Previous page
30
31
32
33
34
35
36
Next page
Last page